| P2093 | author name string | S Vincent Rajkumar | |
| | Vivette D D'Agati | |
| | Sanjeev Sethi | |
| P2860 | cites work | Crystal-storing histiocytosis: a disorder occurring in plasmacytic tumors expressing immunoglobulin kappa light chain | Q73430024 |
| | The kidney in plasma cell dyscrasias: Bence-Jones cast nephropathy and light chain deposit disease | Q77308880 |
| | Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features | Q78351848 |
| | Immunofluorescence on pronase-digested paraffin sections: a valuable salvage technique for renal biopsies | Q79298182 |
| | Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients | Q80186286 |
| | Dysproteinemia-related nephropathy associated with crystal-storing histiocytosis | Q83840883 |
| | The morphologic spectrum and clinical significance of light chain proximal tubulopathy with and without crystal formation | Q84436608 |
| | C3 glomerulopathy associated with monoclonal Ig is a distinct subtype | Q88578407 |
| | Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma | Q24647620 |
| | Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains | Q28219000 |
| | Membranoproliferative glomerulonephritis--a new look at an old entity | Q28262402 |
| | Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases. | Q31118069 |
| | Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome | Q33372850 |
| | Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients | Q33381183 |
| | Atypical hemolytic-uremic syndrome | Q33386736 |
| | Refractory atypical hemolytic uremic syndrome with monoclonal gammopathy responsive to bortezomib-based therapy | Q33418384 |
| | Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens | Q33508070 |
| | Heavy chain deposition disease: the disease spectrum | Q33600131 |
| | Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis | Q33704832 |
| | Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy. | Q33827448 |
| | Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement | Q33849695 |
| | Adult Fanconi syndrome secondary to light chain gammopathy. Clinicopathologic heterogeneity and unusual features in 11 patients | Q33904946 |
| | Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study | Q33997173 |
| | Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis. | Q34229134 |
| | C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up | Q34295006 |
| | Immunotactoid glomerulopathy: clinicopathologic and proteomic study | Q34370571 |
| | How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing. | Q34403114 |
| | International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma | Q34450381 |
| | Crystal-storing histiocytosis involving the kidney in a low-grade B-cell lymphoproliferative disorder | Q34482873 |
| | Proliferative Glomerulonephritis with Monoclonal IgG Deposits Recurs in the Allograft | Q34497181 |
| | Prevalence of monoclonal gammopathy of undetermined significance | Q34506801 |
| | Immunotactoid glomerulopathy | Q34605751 |
| | Mass spectrometry based proteomics in the diagnosis of kidney disease | Q34613978 |
| | Fibrillary glomerulonephritis: a report of 66 cases from a single institution. | Q34751841 |
| | Membranoproliferative glomerulonephritis: the role for laser microdissection and mass spectrometry | Q35021982 |
| | Crystalglobulin-induced nephropathy | Q35124275 |
| | Leukocyte chemotactic factor 2 amyloidosis cannot be reliably diagnosed by immunohistochemical staining | Q35162396 |
| | Crystalloid glomerulopathy in monoclonal gammopathy of renal significance (MGRS) | Q35227558 |
| | IgD heavy-chain deposition disease: detection by laser microdissection and mass spectrometry | Q35240658 |
| | Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors | Q35600166 |
| | Dysproteinemia and the kidney | Q35608123 |
| | C3 glomerulonephritis associated with monoclonal gammopathy: a case series. | Q35618793 |
| | Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association? | Q35983428 |
| | Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy | Q36244981 |
| | Membranoproliferative glomerulonephritis with masked monotypic immunoglobulin deposits | Q36394063 |
| | Dangerous small B-cell clones. | Q36516158 |
| | Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis | Q36938784 |
| | Proliferative glomerulonephritis with monoclonal IgG deposits. | Q37330535 |
| | C3 glomerulopathy: consensus report | Q37348685 |
| | Dense Deposit Disease Associated With Monoclonal Gammopathy of Undetermined Significance | Q37673264 |
| | The cryoglobulinaemias | Q37922370 |
| | Renal crescentic alpha heavy chain deposition disease: a report of 3 cases and review of the literature | Q37938212 |
| | Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant | Q38050703 |
| | How I treat monoclonal gammopathy of renal significance (MGRS). | Q38151021 |
| | Monoclonal gammopathy-associated proliferative glomerulonephritis | Q38158504 |
| | Diagnosis of monoclonal gammopathy of renal significance | Q38326729 |
| | Toward a working definition of C3 glomerulopathy by immunofluorescence | Q38394841 |
| | Hematologic characteristics of proliferative glomerulonephritides with nonorganized monoclonal immunoglobulin deposits | Q38458283 |
| | Renal lesions associated with plasma cell dyscrasias: practical approach to diagnosis, new concepts, and challenges | Q39065507 |
| | Light Chain Proximal Tubulopathy: Clinical and Pathologic Characteristics in the Modern Treatment Era. | Q40775672 |
| | Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy | Q40846575 |
| | A practical approach to the diagnosis of systemic amyloidoses. | Q41505050 |
| | Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease | Q41847394 |
| | Renal monoclonal immunoglobulin deposition disease: the disease spectrum | Q43651998 |
| | Crystal-storing histiocytosis with renal Fanconi syndrome: pathological and molecular characteristics compared with classical myeloma-associated Fanconi syndrome. | Q44027172 |
| | Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features | Q44358759 |
| | DnaJ Homolog Subfamily B Member 9 Is a Putative Autoantigen in Fibrillary GN. | Q47447490 |
| | DnaJ Heat Shock Protein Family B Member 9 Is a Novel Biomarker for Fibrillary GN. | Q47447503 |
| | The clinicopathologic characteristics of kidney diseases related to monotypic IgA deposits. | Q50961285 |
| | Thrombotic microangiopathy associated with monoclonal gammopathy. | Q50998724 |
| | Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management. | Q51368332 |
| | Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome: a retrospective series of 49 patients. | Q51630818 |
| | A long-term study of prognosis in monoclonal gammopathy of undetermined significance. | Q55035699 |
| | Renal Monoclonal Immunoglobulin Deposition Disease: A Report of 64 Patients from a Single Institution | Q56658531 |
| | Nodular glomerulosclerosis with deposition of monoclonal immunoglobulin heavy chains lacking C(H)1 | Q56908299 |
| | Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascular-limited deposition in the kidney | Q60976535 |
| | Clinicopathologic Correlations in Multiple Myeloma: A Case Series of 190 Patients With Kidney Biopsies | Q60976536 |
| | Crystal-storing histiocytosis and crystalline tissue deposition in multiple myeloma | Q70134377 |
| | Crystalglobulinemia syndrome. A manifestation of multiple myeloma | Q70566499 |
| P577 | publication date | 2018-04-27 | |
| P1433 | published in | Journal of the American Society of Nephrology | Q17123893 |
| P1476 | title | The Complexity and Heterogeneity of Monoclonal Immunoglobulin-Associated Renal Diseases. | |